Peficitinib (hydrochloride)


CAS No. : 1353219-06-3

(Synonyms: ASP015K (hydrochloride); JNJ-54781532 (hydrochloride))

1353219-06-3
Price and Availability of CAS No. : 1353219-06-3
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-19568B
M.Wt: 362.85
Formula: C18H23ClN4O2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1353219-06-3 :

Peficitinib (ASP015K) hydrochloride is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1]. IC50 & Target: IC50: 3.9 nM (JAK1), 5.0 nM (JAK2), 0.7 nM (JAK3), 4.8 nM (Tyk2)[1] In Vitro: Peficitinib hydrobromide (0-100 nM; 3 days) inhibits IL-2-induced T cell proliferation in a concentration-dependent manner[1].
Peficitinib hydrobromide (10-1000 nM) inhibits IL-2-induced STAT5 phosphorylation in a concentration-dependent manner with a mean IC50 of 124 nM in rat whole blood, and inhibits STAT5 phosphorylation with a mean IC50 of 127 nM in human lymphocytes[1]. In Vivo: Peficitinib hydrobromide (1-30 mg/kg; p.o.; once daily for 24 days) shows dose-dependent efficacy both in prophylactic and therapeutic dosing regimens in an adjuvant-induced arthritis rat model[1].

Your information is safe with us.